Today, we’re excited to launch Feedly for Biopharma to help biopharma professionals cut through the noise. We’ve designed a collection of integrations and Leo models specifically designed to help you find the information you need, break barriers between teams, and streamline open-source intelligence.
280,000 biopharma professionals already use Feedly to keep up with the latest biopharma news and research insights about topics like diseases and conditions, genes, and competitors.
Biopharma is a competitive space. It is key for pharma and biotech companies to keep ahead of their competition and to be aware of the latest scientific and technological breakthroughs.
Learning more about the diseases and methodologies that are being researched by other biopharma companies can help you better prepare your strategic plans and research programs. According to a new analysis published in JAMA in March 2020, the cost to develop a new drug for a US biopharma company is $1 billion.
With hundreds of articles, scientific publications, and regulatory updates to read and organize every day, biopharma intelligence research is overwhelming. Finding the information you need in that sea of information is time-consuming and tedious. We’re launching Feedly for Biopharma to help biopharma professionals cut through the noise and save time.
Follow the biopharma sources you need
We’ve hand-picked the best sources in your industry to create biopharma bundles so you can keep up with trends. Choose any of the bundles below to see the different bundles of sources.